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Edited by Felix WielandAbstract The highly polymorphic major histocompatibility
complex class II (MHCII) polypeptides assemble in the ER with
the assistance of invariant chain (Ii) chaperone. Ii binds to the
peptide-binding pocket of MHCII heterodimers. We explored
the mechanism how MHCII subunits attach to Ii. Expression
with single a or b subunits from three human HLA and two
mouse H2 class II isotypes revealed that Ii co-isolates predomi-
nantly with the a polypeptide. Co-isolation with a chain requires
the groove binding Ii-segment and depends on M91 of Ii. Immu-
noprecipitation of Ii from pulse chase labeled cells showed
sequential assembly of a and b chains.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The major histocompatibility complex (MHC) encodes
highly polymorphic polypeptides that serve the immune system
as peptide receptors. Early in biosynthesis invariant chain (Ii)
acts as a chaperone by assisting initial folding and oligomeri-
sation of the MHCII subunits [1]. Ii is a non-polymorphic type
II membrane protein that has important functions in the
MHCII processing pathway. Ii promotes MHCII antigen pro-
cessing and presentation [2]. In the absence of Ii, MHCII a and
b chains bind to unfolded ER polypeptides and are largely
contained in aggregates, including the immunoglobulin bind-
ing protein [3–5]. Ii binds to the peptide binding cleft and to
some other regions of ab heterodimers and stabilizes the con-
formation of MHCII molecules [6,7]. Amino acid residues
M91, A94 and M99 of Ii bind to pockets one, four and nine that
are formed in the peptide binding groove of MHCII heterodi-
mers. While pocket one mainly consists of aa residues from the
a chain, both, a and b chain residues form the other pockets
[8]. After assembly has been ﬁnished the MHCII/Ii complex
passes the ER quality control system and traﬃcs to the Golgi
compartment. The LI and ML sequence motifs on the cyto-
plasmic tail of Ii target MHCII/Ii oligomers to the endocytic
pathway [9,10].Abbreviations: MHCII, MHC class II; Ii, invariant chain; DR,
HLA-DR
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lum with MHCII a and b polypeptides [11]. Since numerous
MHCII isotype and allotype subunits are expressed in an anti-
gen presenting cell, examination of MHCII assembly is diﬃ-
cult to achieve. The models for MHCII subunits assembly
therefore remain controversial [12,13]. We used a transient
expression system to examine interaction of Ii to single MHCII
subunits. Our study revealed that Ii and MHCII a chains form
NP40 stable complexes. Binding of Ii to a depends on the sin-
gle methionine residue IiM91. Pulse chase labeling experiments
of antigen presenting cells and immunoprecipitation of Ii sug-
gest that b chain can be attached to an aIi matrix.2. Materials and methods
2.1. DNA constructs
HLA-DRa and -DRB1*010101 were obtained from Dr. H. Ploegh.
HLA-DQA1*0301 and HLA-DQB1*0302 were obtained from Dr. U.
Gru¨neberg and subcloned from pCEP4 into the pcDNA3.1/V5His
expression vector. HLA-DPA1*010301 and HLA-DPB1*0401 were
RT-PCR ampliﬁed from dendritic cells, and I-Ab and IEd from spleno-
cytes of C57BL/6 and of BALB/c mice. A V5His epitope was added to
the C-terminus of the a- and b chains of DQ, DP, I-A and I-E subunits.
The primer sequences are as follows: DPa.uni (5 0-CACCATGCGCCC-
TGAAGACAGAATGTT-30), DPa.rev (50-CAGGGTCCCCTGGGCC-
CGG-30),DQa.uni (50-CACCATGATCCTAAACAAAGCTCTGC-30),
DQa.rev (5 0-CAATGGCCCTTGGTGTCTGG-30),DQb.uni (5 0-CAC-
CATGGGTTCTGGGTGGGTCCC-3 0), DQb.rev (5 0-GCATGACT-
GAGGGAGCAGAAC-30). I-Aa.uni (5 0-CACCATGCCGCGCAG-
CAGAGCTCTG-3 0), I-Aa.rev (5 0-TAAAGGCCCTGGGTGTCTG-
GAG-3 0), I-Ab.uni (5 0-CACCATGGCTCTGCAGATCCCCAGC-3 0),
I-Ab.rev (5 0-CTGCAGGAGCCCTGCTGGAGG-3 0), I-Ea.uni (5 0-
CACCATGGCCACAATTGGAGCCCTGC-3 0), I-Ea.rev (5 0-CAG-
GGCTCCTTGTCGGCGTTC-3 0), I-Eb.uni (5 0-CACCATGGTGTG-
GCTCCCCAGAGTTCCC-3 0), I-Eb.rev (5 0-GCTCAGGAGTCCT-
GTTGGCTG-3 0). The sequence of all constructs was conﬁrmed by
sequencing.Two IiDNAconstructswere prepared.One construct shows
a deletion of the coding sequence for aa 91–99, and one an exchange of
M91 to G. Both DNA constructs were prepared by overlap extension
PCR with the primers as follows: Ii.uni (5 0-CCAGTCATGGATGAC-
CAGCGC-3 0) and the mutagenic anti-sense primer IiD91–99.rev (5 0-
GGCTCCCATGGGCAGCGCCTGCTTGCTCACAGGCTTGGG-
AGG-3 0) or IiM91G.rev (5 0-GGTGGCCATGCGCCCCTTGCTCAC-
AGGCTTGGGAGG-3 0). The mutagenic sense primers IiD91–99.uni
(5 0-CAGGCGCTGCCCATGGGAGCC-3 0) or IiM91G.uni (5 0-AAG-
CCTGTGAGCAAGGGGCGCATGGCCACCCCGCTGCTGATG-
C-3 0) and the Ii reverse primer Ii.rev (5 0-TCACAGATGGAGA-
TTGGGCAGCAGG-3 0). The mutated sequences were cloned into
expression vector pcDNA3.1 and conﬁrmed by sequencing.
2.2. Cells, mice, antibodies and cell transfection
COS-7 cells were obtained from the American Type Culture Collec-
tion. The human ﬁbroblast cell line IMRS was purchase by the Coriell
Institute (Camden, NJ). The rabbit antiserum S35 against the DRbation of European Biochemical Societies.
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bodies anti-DRa 1B5, anti-Ii Bu43, and In-1 have been described [14–
17]. Anti-His and anti-V5 mAbs were purchased from Invitrogen.
Transgenic Ii41 mice were used as a source for splenocytes [18].
COS-7 and IMRS cells were transfected with the liposomal reagent
DOSPER (Roche Diagnostics, Mannheim, Germany) and with JetPeir
(QbioGene). Brieﬂy, 1 · 106 cells were transfected with 1lg cDNA.
After 72 h, cells were harvested and subjected to immunoblotting
and immunoprecipitation.
2.3. Metabolic radiolabeling, immunoprecipitations, SDS–PAGE and
immunoblotting
In pulse chase experiments 107 splenocytes were pulsed with 150 lCi
[35S]-methionine. Subsequently, unbound radioactivity was removed
and the incorporated [35S]-methionine was chased by addition of med-
ium containing 100· methionine. Cells were lysed in 0.5% NP40 (Sig-
ma, Taufkirchen, Germany) in Tris, pH 7.4, and cell lysates were
precleared by incubation with CL4B-Sepharose (Amersham, Freiburg,
Germany). Immunocomplexes were isolated using protein A-Sephar-
ose. Subsequently, samples were separated by SDS–PAGE, exposed
to ﬁlms or transferred onto Immobilon P membrane for Western
detection (Millipore, Schwalbach, Germany). The membrane was
blocked in PBS/Roti-Block (Roth, Karlsruhe, Germany), and probed
with antibodies. Bands were visualized with horseradish peroxidase-
conjugated rabbit anti-mouse (Sigma, Taufkirchen, Germany) or goat
anti-rabbit IgG (Sigma, Taufkirchen, Germany) and ECL enhanced
chemiluminescent substrate (Amersham, Freiburg, Germany).3. Results
3.1. Binding of invariant chain to individual MHCII polypeptides
To evaluate the interaction of Ii with individual DR poly-
peptides, Ii was co-expressed with a single DRa or DRb chain
(Fig. 1, lanes 1 and 2). Cells were lysed with NP40, followed by
immunoprecipitation (upper panel) of DRa (lane 1), or DRb
(lane 2) using chain-speciﬁc antibodies. The immunoprecipi-
tates were SDS–PAGE separated and immunoblotted for Ii.
Expression of transfected cDNAs was examined by Western
blotting of cell lysates (Fig. 1, lower panel, lanes 1 and 2).
Detection of Ii (upper panel, lane 1) in immunoprecipitates
of DRa chain indicated that the monomorphic DRa chainFig. 1. Interaction of Ii with single MHCII polypeptides. COS-7 cells were tr
DPb (lane 4), DQa (lane 5), DQb (lane 6), with mouse Ii and I-Aa (lane 7),
DRb were immunoprecipitated (IP) and Western blotted with 1B5 or S35. DP
Immunoprecipitation of DP, DQ, I-A and I-Ea and b chains was conducted w
was co-isolated and detected by Bu43, and mouse Ii was detected with In-1
immunoglobulin, which were used for immunoprecipitation, are indicated.binds to Ii. DRb did not coprecipitate signiﬁcant amounts of
Ii (lane 2). Given the disparate results between co-isolation
of DRa or DRb with Ii, we explored additional MHCII iso-
types in order to examine whether binding of Ii to MHCIIa
chains can be generalized. We employed DP, DQ, I-A and I-
E encoding cDNAs to examine co-isolation of a and b poly-
peptides with human or mouse Ii. The MHCII polypeptides
were tagged with a V5 – followed by a His-epitope. The His-
epitope was used for immunoprecipitation, while co-isolation
of the MHCII polypeptides was monitored by immunoblotting
with anti V5 antibody. COS-7 cells were transfected with Ii and
with single MHCII chains. Immunoprecipitation of MHCII
polypeptides from cell lysates and immunoblotting for human
Ii (Fig. 1, upper panel, lanes 3–6) or mouse Ii (Fig. 1, upper
panel, lanes 7–10) revealed that Ii orthologs were co-isolated
with DPa, DQa, I-Aa and I-Ea polypeptides (Fig. 1, upper pa-
nel, lanes 3, 5, 7 and 9). The result of Western blotting of cell
lysates is shown in the lower panel. In DPb, DQb and I-Ab
immunoprecipitates, immunoblotting revealed no Ii band
(Fig. 1, upper panel, lanes 4, 6 and 8). Isolation of I-Eb chain
yielded low amounts of Ii detected by Western blotting
(Fig. 1A, upper panel, lane10). This result indicates that Ii
was co-isolated with the ﬁve MHCIIa isotypes from NP40 cell
lysates. Evaluation of the band intensities revealed that the
interaction of Ii with MHCIIb chains in NP40 lysates was
more than one order of magnitude weaker than interaction
with MHCIIa and could be detected only upon appropriate
long exposure of the blot.This result was conﬁrmed by immu-
noprecipitation of metabolically labeled human IMRS cells
transfected with a and Ii encoding cDNAs (data not shown).
3.2. Interaction of Ii to DRa
The X-ray structure of the Ii-fragment CLIP bound to
DRab dimers revealed interaction of numerous DR – with
Ii-residues [8]. To test, whether interaction of Ii to DRa solely
depends on the groove binding segment of Ii, the deletion mu-
tant IiD91–99 was co-expressed with DRa (Fig. 2A). Immuno-
precipitation of DRa, subsequent SDS–PAGE separation andansfected with human Ii and DRa (lane 1), DRb (lane 2), DPa (lane 3),
I-Ab (lane 8), I-Ea (lane 9), I-Eb (lane 10) encoding cDNAs. DRa and
, DQ, I-A and I-E polypeptides were tagged with His- and V5 epitopes.
ith mAbs against His and V5 was used for Western blotting. Human Ii
. On the upper left, the position of heavy (H) and light (L) chains of
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(lane1), the mutant IiD91–99 (lane 2) does not co-isolate with
DRa and suggests that the interaction largely occurs within the
MHCII groove. Lanes 3–6 exhibit expression of the polypep-
tides. To rule out that ineﬃcient folding of IiD91–99 impacts
on co-isolation with MHCII, a mutation was introduced into
full length Ii. M91 of Ii binds to the ﬁrst pocket in the MHCII
cleft [8]. This ﬁrst pocket is the most conserved pocket (75%)
within the MHCII groove. It is possible, that binding of Ii to
single DRa chain abundantly depends on M91 of Ii. WeFig. 2. Interaction of Ii to MHCII a chains. (A) Deletion of aa residues 91–9
(lanes 1, 3, and 5) or with IiD91–99 (lanes 2, 4 and 6) in COS-7 cells. The DRa
and 2) and immunoblotted for Ii with mAb Bu43. Expression of Ii chains and
(B) Mutation of M91 of Ii abolishes binding to MHCII a chains. Ii or IiM91
DQa (lanes 3 and 5). The DRa chain was immunoprecipitated with mAb 1B5
subsequently Western detected for Ii with mAb Bu43 (upper panel). Expressio
with mAb Bu43 (middle panel) or with mAb 1B5 (lower panel, lanes 1 and 4) a
(C) DRa, b and the M91 mutated Ii were expressed in COS-7 cells. DR was im
for Ii. The heavy chain (H) of mAb I251 is indicated.mutated M91 of Ii to G and co-expressed the mutant Ii with
DR, DP and DQ a chains (Fig. 2B). Immunoprecipitation of
a chain and immunoblotting for Ii revealed that the single
mutation of M91 to G almost completely abolished co-isola-
tion of the mutant Ii with MHCII a chains from NP40 lysates
(lanes 4–6). As a control, single a chains show binding to wild
type Ii (lanes 1–3). Expression of the polypeptides was exam-
ined by Western blotting of cell lysates (lower panels). To ex-
clude that the lack of co-isolation with DRa was caused by
sterical hindrance, we examined the mutant Ii M91 for binding9 of Ii abolishes binding to DRa chain. DRa was co-expressed with Ii
chain was immunoprecipitated from cell lysates with mAb 1B5 (lanes 1
of DRa was monitored by Western blotting of cell lysates (lanes 3–6).
G was co-expressed with DRa (lanes 1 and 4), DPa (lanes 2 and 6) or
(lane 1, 4), DPa and DQa with anti His mAb (lanes 2, 5 and 3, 6) and
n of the polypeptides was monitored by Western blotting of cell lysates
nd with mAb V5 (lower panel, lanes 2, 3 and 5, 6) for the alpha-chains.
munoprecipitated from cell lysates with mAb I251 and immunoblotted
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tation of DR with a conformation-sensitve Ab, which detects
DR molecules when they are assembled to heterodimers. The
DR immunoprecipitate co-isolates the mutant Ii, which was
detected by immunoblotting. The results shown in Fig. 2 were
reproduced in human IMRS cells with DR, DP and DQ het-
erodimers (data not shown).
3.3. Assembly of MHCII a and b chains to Ii
Co-isolation of MHCIIa chain with Ii could suggest a
sequential assembly of Ii with a and b subunits. We examined
assembly of MHCII subunits in a pulse chase experiment. To
circumvent co-migration of Ii with a and b subunits in SDS
gels, we made use of a transgenic mouse line that solely ex-
presses the Ii41 isoform of Ii [18]. Ii41 has a m.w. of 41 kDa
and no distinct Ii41-derived band co-migrates with a
(34 kDa) and b (28 kDa) chains.
Splenocytes from Ii41 transgenic mice were 5 min pulse
labeled with [35S]-methionine and subsequently chased for 5,
10, 15 and 20 min. Cells were lysed and Ii was immunoprecip-
itated by a serum raised against recombinant Ii. SDS–PAGE
separation of the immunoprecipitates is shown in Fig. 3 (upper
panel). Ii appears in several bands, which were explained by
diﬀerential gylcosylation [19]. The position of a and b chains
was veriﬁed by immunoprecipitation of Aab and Abb from
transfected COS-7 cells (Fig. 3, upper panel, lanes 6 and 7).
Notice, that Aab contains two and Abb four methionine resi-
dues. After a 5 min pulse, the band intensity of a chain exceeds
that of b chain. Hence, immunoisolation of Ii revealed appear-
ance of a before b chain. Within a 5 min chase the mobility of
a and b chains increases. A reduced size of a and b chains upon
a 5 min chase is best explained by early trimming of high man-
nose carbohydrates (compare lanes 1 and 2). Within 5 min of
chase (lane 2) intensity of the b chain band increases, suggest-
ing that b chain is added to the aIi complex. In the following
chase times (lanes 3 to 5), the b band intensity exceeds that of
the a band. The result indicates that MHCII assembly is a ra-Fig. 3. Pulse chase labeling of mouse splenocytes. Splenocytes from
tgIi41 mice were 5 min pulse labeled with [35S]-methionine (upper and
lower panel) and subsequently chased after addition of medium
containing 100· unlabeled methionine for the times indicated on the
top of the ﬁgures. Ii41 was immunoprecipitated with S22 and separated
by SDS–PAGE (upper panel, lanes 1–5; lower panel, lanes 1–3).
Immunoprecipitation of Aab or Abb from transfected COS-7 cells
indicate the position of a and b chains (upper panel, lanes 6 and 7).
Bands corresponding to Ii41, a and b were indicated on the left.pid event and therefore, the pulse chase experiment was re-
peated within four min of chase (Fig. 3, lower panel). Again,
immunoprecipitation of Ii from 5 min pulse labeled cells
(lane1) shows a distinct a band and a small amount of b chain.
Intensity of b chain increases within 2 min of chase (lane 2).
After 4 min chase (lane 3) the amount of label in the b chain
band exceeds that of the a chain band.4. Discussion
Assembly of MHCII subunits is tightly connected to the ER
quality control system. After biosynthesis, MHCII subunits
are transiently contained in high molecular weight aggregates
[20]. These high molecular weight complexes contain Bip, caln-
exin and possibly other not yet identiﬁed chaperones [20].
Binding of antibodies to MHCII epitopes that are exposed
only on ab heterodimers indicate that the MHCII subunits
are contained in dimers, which are at least partially folded.
Assembly of Ii and MHCII subunits in a cell free system sug-
gested that Ii binds to a preformed ab heterodimer [21]. It re-
mains diﬃcult to understand, how three ab heterodimers are
attached with their peptide-binding pockets to a complex of
three Ii chains. A role of Ii could be to dissociate and to reas-
semble ab chains from high molecular aggregates. Our results
indicate that Ii is capable to assemble to single MHCII a
chains. The large excess of Ii compared to the amount of
MHCII subunits expressed in antigen presenting cells may
favor formation of the aIi matrix versus ab dimers. We suggest
that aIi forms a scaﬀold for subsequent binding of b chain.
This model could explain how the oligomeric MHCII/Ii com-
plex is formed, namely by sequential addition of a and b
subunits to a preformed Ii trimer.
Co-isolation of Ii with single a chain depends on aa residue
IiM91. The demonstrated interaction of Ii to the DRa subunit
is consistent with binding of the Ii fragment CLIP to the DR3
ab dimer [8]. The MHCII groove contains several anchor posi-
tions for binding of CLIP [18,22]. Hence, binding of antigenic
peptides to MHCII heterodimers was only partially inhibited
by a M91 mutant of CLIP [23]. However, the importance of
the single methionine residue that controls binding of Ii to
DRa could explain how CLIP is released from the MHCII
groove. A conformational change of MHCII induced by inter-
action to DM could impact on the ﬁrst pocket and facilitate
dissociation of CLIP.
The here proposed molecular mechanism for MHCII sub-
unit assembly could explain how in antigen presenting cells
the MHCII/Ii oligomer is assembled and how isotype-matched
MHCII heterodimers are formed.
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